Light can tell you a lot about what matter is doing. Visible light shows a surface. X-rays reveal hidden structure. Infrared ...
BOULDER, Colo., Jan. 8, 2026 /PRNewswire/ -- Enliven Therapeutics, Inc. (Enliven or the Company) (Nasdaq: ELVN), a clinical-stage biopharmaceutical company focused on the discovery and development of ...
Exelixis (EXEL) stock analysis: 14x 2026E EPS vs. sector, cabozantinib growth, zanzalintinib upside, and FDA/Q4 catalysts.
Novartis AG (NYSE:NVS) Q4 2025 Earnings Call Transcript February 4, 2026 Novartis AG beats earnings expectations. Reported ...
Strong PALSONIFY U.S. Launch Execution Resulted in Unaudited and Preliminary Net Product Revenue of >$5 Million for Fourth-Quarter 2025, with >200 Enrollment Forms at the End of December Atumelnant ...
Taurine from octopus and squid neutralizes oxygen radicals that destroy perovskite solar cells, then regenerates to provide ...
Q4 2025 Earnings Call February 5, 2026 5:00 AM ESTCompany ParticipantsSimon Østergaard - CEO & PresidentMonica Jonsson ...
Teresa Ribera has completed her first year at the helm of the European Commission’s competition directorate (“DG COMP”). It was a year in which ...
Shares of Corvus Pharmaceuticals rose after its investigational drug soquelitinib showed positive results in an early-stage trial in atopic dermatitis patients. The stock surged 50% to $12.10 in ...
Bristol-Myers Squibb Company (NYSE:BMY) is one of the cheap S&P 500 stocks to invest in now. On January 12, Bristol-Myers Squibb announced positive topline results from its Phase 3 SCOUT-HCM clinical ...